Digesticann® - SALE 30%
New unique formulation of CBD capsules contains full spectrum CBD oil 6% in organic sesame seed oil, 40+ terpenes and flavonoids and Mint Oil.
CBD/CBDA: 20 mg/cps + Mint Oil 150 mg/cps
Total content CBD/CBDA is 600 mg per box.
Terpenes: 22,67 mg/g
Packaging: 30 cps/box
Suitable for all diets and religions, 100% plant based.
Novel FoodContributes to the normal Intestinal and Digestive Function
Contributes to the normal Gall Bladder Function
Contributes to the normal Liver Function
Contributes to the natural function of the Immune system
Manufactured by Pharmaceutical EU GMP and FDA certified factory.
Certification is available on request.
Under Novel Food registration process by EFSA*.
One capsule contains 20 of high GMP quality Canabidiol & Cannabidiolic acid 20 mg in Organic Sesame Seed Oil with rich terpene profile and 150mg of Peppermint oil.
Contributes to the normal Intestinal and Digestive Function.
Contributes to the normal Gall Bladder Function.
Contributes to the normal Liver Function.
Contributes to the natural function of the Immune system.
Vegan capsule (hydroxy- propyl-methyl cellulose), gellan gum. For oral use only. The product is manufactured under strict adherence to the requirements of good manufacturing practice (GMP), documented by the internationally valid GMP certificate and is verified by regular inspections by the
State Institute for Drug Control.
1-2capsules/day (swallow with water).
This product is not suitable for children under 3 years old, pregnant and breastfeeding women.
Don’t exceed the recommended daily dose.
Product is not a substitute for a normal diet. Take care to have a balanced diet and healthy life style. Natural product suitable for vegans.
Keep out of reach of children. Keep in a cold, dark and dry place at the temperature up to 30 °C in the original packaging to protect the product from light and moisture.
* In November 2015, the European Parliament and the Council of the European Union adopted a new regulation on Novel Food, Regulation (EU) 2015/2283, with the intent of making the Novel Food authorization process more efficient while ensuring high standards of food safety or consumers. This new Regulation came into force on 1 January 2018. If lawfully marketed in the EU after 15 May 1997, existing Food Supplement products with Cannabidiol and/or Cannabis Sativa Extract can remain on the market as long as an application for Novel Food authorization is submitted to the European Commission before 1 January 2019.